Product Images Tadalafil

The text describes a combination of medication, Tadalafil 20 mg, and Doxazosin 8 mg, compared to a placebo combined with Doxazosin 8 mg over a period of 24 hours. The rest of the text seems to be random characters and symbols.*

This is a graph showing the plasma concentration of Tadalafil in micrograms per liter (ug/L) over time in hours. The graph compares the results of a single 20 mg dose of Tadalafil, a single 5 mg dose of Tadalafil, and a once-daily 5 mg dose of Tadalafil following five consecutive days of administration. There is no further information available in the text.*

The text shows a graph presenting the change in IPSS (International Prostate Symptom Score) total score between patients who received Tadalafil 5 mg and those who received a placebo over the course of a 12-week treatment. The graph shows that patients who received Tadalafil 5 mg had a statistically significant improvement in their IPSS score compared to those who received a placebo.*

This text provides the change from the baseline score in IPSS (International Prostate Symptom Score) for tadalafil 5mg compared to placebo, with a significant difference (p<0.01). The duration of treatment is not specified.*

This looks like a statistical analysis report comparing the mean change from baseline of two treatment options (TadalafilFinasteride and Placebo/Finasteride) over a period of 26 weeks of therapy, with a comparison at week 12. The "Least-Squares Treatment Difference" refers to a statistical method for comparing the two treatment options.*

The text describes the change from the baseline in the IPSS total score after a certain duration of treatment in weeks for Tadalafil 5 mg and Placebo. The change in score for Tadalafil 5 mg was -4, while for Placebo, it was 3. The results were statistically significant with a P-value of less than or equal to 0.01.*

This is a description of a medication called Tadalafil Tablets, USP. Each tablet contains 2.5 mg of tadalafil USP and is manufactured by Lupin Limited. The recommended dosage is one tablet per day, and the exact dosage should be determined by reviewing the accompanying literature provided by Lupin Pharmaceuticals, Inc. The tablets should be stored at a temperature of 25°C (77°) and should not be split; the entire dose should be taken. The warning states, "Keep out of reach of children," and the tablets should be dispensed in a tight container. Code No.: MH/DRUGS/25-ND/59.*

NDC 68180-920-06 is a medicine that contains 5mg of tadalafil per tablet. The recommended dosage must be read in the accompanying literature. It is advised to store this medicine at a temperature of 25°C (77°F) and in a tight container. The tablets should not be split and the entire dose is recommended to be taken. This medicine must be kept out of the reach of children. This product is manufactured by Lupin Limited in Nagpur, India and distributed by Lupin Pharmaceuticals in Baltimore, United States.*

NDC 68180-921-06 is a medication containing 10mg of tadalafil. It is advised to refer to the accompanying literature for dosage instructions. The tablets should not be split and the entire dose should be taken. This medication should be kept out of reach of children and dispensed from a tightly sealed container. This product is manufactured by Lupin Limited in Nagpur, India for Lupin Pharmaceuticals, Inc. in Baltimore, Maryland. Rx only.*

NDC 68180-922-06 is a medication containing 20mg of tadalafil USP, its usual dosage can be found in the accompanying literature. It should be stored at 77°F and kept away from children in a tight container. The tablets should not be split and the entire dose should be taken. This medication is manufactured by Lupin Pharmaceuticals Inc. in Baltimore, Marylandand by Lupin Limited in Nagpur, India.*